We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Novartis Pharmaceuticals UK Limited is recalling Adakveo 10 mg/ml concentrate for solution for infusion due to the benefit-risk balance of Adakveo no longer being considered favourable by the MHRA.
Find drug safety updates issued by MHRA
Employment Tribunal decision. Employment Tribunal decision.
Information for parents of eligible children aged 6 months to 11 years on COVID-19 vaccination.
Adored Beast products stopped at East Midlands Airport.
Information for people who wish to apply to release a vaccine or a blood product to market in the UK.
This guidance covers ‘grandfathering’ and managing the lifecycle changes of medicinal products.
The estimates as recommended by Public Health England.
Guidance for people aged 12 and over whose immune system means they are at higher risk of serious illness if they become infected with COVID-19.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).